Clinical Trials Browser

Gastrointestinal Neoplasms

Urinary Bladder Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Mesothelioma, Malignant, Mesothelioma

Pancreatic Neoplasms

Pancreatic Neoplasms

Hodgkin Disease, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

CNS Germ Cell Tumor

Pancreatic Neoplasms

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma

Pancreatic Neoplasms

Breast Neoplasms

Adenocarcinoma, Pancreatic Neoplasms

Sarcoma, Ewing

Carcinoma, Transitional Cell

Neoplasms, Pancreatic Neoplasms

Hodgkin Disease

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Small Cell Lung Carcinoma

Urinary Bladder Neoplasms

Adenocarcinoma of the Pancreas

Metastatic HER2-Positive Breast Cancer

Nasopharyngeal Carcinoma

Pancreatic Neoplasms

Pancreatic Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

HER2-negative Metastatic Breast Cancer

Breast Neoplasms

Pancreatic Neoplasms

Metastatic Pancreatic Ductal Adenocarcinoma

Pancreatic Neoplasms

Cholangiocarcinoma

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Leukemia, Plasma Cell, Multiple Myeloma, Plasmacytoma

Mesothelioma

Pancreatic Neoplasms

Diffuse Intrinsic Pontine Glioma

Carcinoma, Non-Small-Cell Lung, Neoplasms

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, T-Cell

Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Urinary Bladder Neoplasms

Microphthalmia, Isolated, with Coloboma 5, Brain Neoplasms, Medulloblastoma, Central Nervous System Neoplasms

Pancreatic Cancer Resectable

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Lymphoma, Non-Hodgkin

Pancreatic Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Clinical Trials

BREGO

Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy

GEMMK

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer

Pancreas

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer

PINBALL

Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant

Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)

Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I

NIFE

Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer

PRECIOUS

A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)

A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor

Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma

Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer

Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Study of Brentuximab Vedotin in Patients With R/R PTCL Treated With Gemcitabine

Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer

BLAST

A Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer

Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy

PLATINUM

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

FUNGEMAX

EUDARIO

Adaptive Therapy for Post-Second-Line Advanced Breast Cancer

T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer

Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer

PanCAN-SR1

Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer

Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)

Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects

Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma

RAMES

LAPTOP

Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma

EURTAC

Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

ADAPT

Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer

Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer

Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors

Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer

The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer

NIVEAU

Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer

Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer